Table 1.
Participant characteristics
| Brain Tumor (n = 18) |
Typically Developing (n = 18) |
|
|---|---|---|
| Variables | n (%) or M ± SD | n (%) or M ± SD |
|
| ||
| Age in years | 13.9 ± 2.9 | 13.5 ± 2.2 |
| Female sex | 8 (44.4%) | 7 (38.9%) |
| Race | ||
| Caucasian | 14 (77.8%) | 8 (44.4%) |
| African-American | 2 (11.1%) | 5 (27.8%) |
| Asian | 1 (5.6%) | 0 |
| Multi-ethnic | 0 | 3 (16.7%) |
| Other | 0 | 1 (5.6%) |
| Unreported | 1 (5.6%) | |
| Hispanic/Latinx | ||
| Hispanic/Latinx | 2 (11.1%) | 4 (22.2%) |
| Not Hispanic/Latinx | 13 (72.2%) | 12 (66.7%) |
| Unreported | 3 (16.7%) | 0 |
| Handedness | ||
| Right dominant | 14 (77.8%) | 18 (100%) |
| Left dominant | 3 (16.7%) | 0 |
| Unreported | 1 (5.6%) | 0 |
| Tumor characteristics | ||
| Age at diagnosis | 6.1 ± 3.3 | |
| Tumor types | ||
| Low grade glioma | 8 (44.4%) | |
| Medulloblastoma | 4 (22.2%) | |
| Ependymoma | 2 (11.1%) | |
| Ganglioglioma | 1 (5.6%) | |
| Glioma | 1 (5.6%) | |
| Primitive neuro-ectodermal tumor | 1 (5.6%) | |
| WHO grade | ||
| I | 10 (55.6%) | |
| II | 2 (11.1%) | |
| III | 0 | |
| IV | 5 (27.8%) | |
| Tumor location | ||
| Supratentorial | 5 (27.8%) | |
| Infratentorial | 12 (66.7%) | |
| Unreported | 1 (5.6%) | |
| Treatment | ||
| Surgery only | 7 (38.9%) | |
| Radiation only | 0 | |
| Chemo only | 2 (11.1%) | |
| Surgery + radiation | 2 (11.1%) | |
| Surgery + chemo | 1 (5.6%) | |
| Radiation + chemo | 0 | |
| All three | 5 (27.8%) | |
| Unreported | 1 (5.6%) | |